Backenroth Samuel

CIK 00015798872 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001579887

Recent Transactions

32 trades

Exercise/Conversion
Notable Labs, Ltd.
Restricted Stock Units
2023-03-31−525,000→ 175,000 total
Exercise/Conversion
Notable Labs, Ltd.
Ordinary Shares
2023-03-31+525,000→ 525,000 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2020-12-29+41,915→ 41,915 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2020-04-30$6.00/sh+1,000→ 11,630 total
Other
NeuBase Therapeutics, Inc.
Employee stock option (right to buy)
2019-07-12+3,000→ 0 total
Award
NeuBase Therapeutics, Inc.
Employee stock option (right to buy)
2019-07-12+772,923→ 772,923 total
Award
NeuBase Therapeutics, Inc.
Stock Option (right to buy)
2017-10-16+350,000→ 350,000 total
Purchase
NeuBase Therapeutics, Inc.
Warrants (right to buy)
2017-04-10+50,001→ 50,001 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2017-04-10$0.70/sh+71,429→ 212,596 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.87/sh+450→ 139,167 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.89/sh+10→ 138,709 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.71/sh+200→ 141,167 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.88/sh+8→ 138,717 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-06-20$2.84/sh+1,800→ 140,967 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.18/sh+192→ 136,955 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.23/sh+163→ 136,362 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.21/sh+184→ 136,557 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.16/sh+379→ 138,168 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.11/sh+33→ 138,699 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.22/sh+11→ 136,373 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.19/sh+152→ 136,763 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.17/sh+834→ 137,789 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.15/sh+184→ 138,352 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.13/sh+11→ 138,503 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.13/sh+97→ 138,492 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.12/sh+163→ 138,666 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.20/sh+54→ 136,611 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-05-23$3.14/sh+43→ 138,395 total
Award
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2016-01-07+130,000→ 136,199 total
Award
NeuBase Therapeutics, Inc.
Option
2015-03-10+60,000→ 60,000 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock, par value $0.0001 per share
2015-02-06$6.75/sh+1,500→ 6,199 total
Award
NeuBase Therapeutics, Inc.
Option
2014-02-03+250,000→ 454,700 total

Companies

Recent Filings

Address

489 5TH AVE., 28TH FLOOR

NEW YORK, NY, 10017

View on SEC.gov